Marcus D Flather
Impact in
- Cardiology and Cardiovascular Medicine top 0.02%
- Acute Myocardial Infarction Research
- Antiplatelet Therapy and Cardiovascular Diseases
- Atrial Fibrillation Management and Outcomes
- Heart Failure Treatment and Management
- Cardiovascular Function and Risk Factors
- Internal Medicine top 0.1%
Papers in
-
- Acute Myocardial Infarction Research 46
- Heart Failure Treatment and Management 36
- Antiplatelet Therapy and Cardiovascular Diseases 30
- Cardiac Valve Diseases and Treatments 24
- Atrial Fibrillation Management and Outcomes 16
- Surgery 75
- Cardiac and Coronary Surgery Techniques 32
- Coronary Interventions and Diagnostics 24
- Co-authors
- Keith A.A. Fox (18 shared papers)Kim Allen Eagle (5 shared papers)Salim Yusuf (20 shared papers)Shaun G. Goodman (9 shared papers)Philippe Gabríel Steg (14 shared papers)Christopher Bull Granger (7 shared papers)Álvaro Avezum (12 shared papers)Robert Joel Goldberg (4 shared papers)
- Journals
- European Heart Journal (29 papers)Journal of the American College of Cardiology (25 papers)The Lancet (22 papers)Circulation (21 papers)International Journal of Cardiology (17 papers)
- Partner nations
- United KingdomUnited StatesCanada
In The Last Decade
Marcus D Flather
306 papers receiving 45.0k citations
Marcus D Flather's Hit Papers
Peers
Comparison fields: 5 of 183
- Cardiology and Cardiovascular Medicine 24.8k
- Internal Medicine 2.5k
- Surgery 11.3k
- Radiology, Nuclear Medicine and Imaging 4.3k
- Immunology 3.3k
Countries citing papers authored by Marcus D Flather
This map shows the geographic impact of Marcus D Flather's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marcus D Flather with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marcus D Flather more than expected).
Fields of papers citing papers by Marcus D Flather
This network shows the impact of papers produced by Marcus D Flather. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marcus D Flather. The network helps show where Marcus D Flather may publish in the future.
Co-authors
The 25 scholars most cited alongside Marcus D Flather, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 321 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease Hit paper breakdown → | 2017 | 7350 |
| 2 | COLLABORATIVE OVERVIEW OF RANDOMIZED TRIALS OF ANTIPLATELET THERAPY .1. PREVENTION OF DEATH, MYOCARDIAL-INFARCTION, AND STROKE BY PROLONGED ANTIPLATELET THERAPY IN VARIOUS CATEGORIES OF PATIENTS Hit paper breakdown → | 1994 | 2867 |
| 3 | Clopidogrel and Aspirin versus Aspirin Alone for the Prevention of Atherothrombotic Events Hit paper breakdown → | 2006 | 2135 |
| 4 | 2023 ESC Guidelines for the management of cardiomyopathies Hit paper breakdown → | 2023 | 1451 |
| 5 | A Validated Prediction Model for All Forms of Acute Coronary Syndrome Hit paper breakdown → | 2004 | 1307 |
| 6 | Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE) Hit paper breakdown → | 2006 | 1273 |
| 7 | Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS) Hit paper breakdown → | 2005 | 1261 |
| 8 | Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients Hit paper breakdown → | 2000 | 1199 |
| 9 | ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: executive summary Hit paper breakdown → | 2001 | 1123 |
| 10 | Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial Hit paper breakdown → | 2017 | 1106 |
| 11 | ISIS-4 - A randomised factorial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58.050 patient with suspected acute myocardial-infarction. Hit paper breakdown → | 1995 | 966 |
| 12 | Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trial Hit paper breakdown → | 2010 | 811 |
| 13 | European Society of Cardiology: Cardiovascular Disease Statistics 2019 Hit paper breakdown → | 2019 | 802 |
| 14 | Apixaban with Antiplatelet Therapy after Acute Coronary Syndrome Hit paper breakdown → | 2011 | 788 |
| 15 | European Society of Cardiology: cardiovascular disease statistics 2021 Hit paper breakdown → | 2021 | 785 |
| 16 | ISIS-3 - A RANDOMIZED COMPARISON OF STREPTOKINASE VS TISSUE PLASMINOGEN-ACTIVATOR VS ANISTREPLASE AND OF ASPIRIN PLUS HEPARIN VS ASPIRIN ALONE AMONG 41,299 CASES OF SUSPECTED ACUTE MYOCARDIAL-INFARCTION Hit paper breakdown → | 1992 | 757 |
| 17 | Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial Hit paper breakdown → | 2017 | 743 |
| 18 | Decline in Rates of Death and Heart Failure in Acute Coronary Syndromes, 1999-2006 Hit paper breakdown → | 2007 | 698 |
| 19 | Randomized Trial of Complete Versus Lesion-Only Revascularization in Patients Undergoing Primary Percutaneous Coronary Intervention for STEMI and Multivessel Disease Hit paper breakdown → | 2015 | 637 |
| 20 | Patients With Prior Myocardial Infarction, Stroke, or Symptomatic Peripheral Arterial Disease in the CHARISMA Trial Hit paper breakdown → | 2007 | 617 |
About Marcus D Flather
Marcus D Flather is a scholar working on Cardiology and Cardiovascular Medicine, Surgery, Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine and Hematology, having authored 321 papers that have together received 47.8k indexed citations. Recurring topics across this work include Acute Myocardial Infarction Research (46 papers), Heart Failure Treatment and Management (36 papers), Cardiac and Coronary Surgery Techniques (32 papers), Antiplatelet Therapy and Cardiovascular Diseases (30 papers), Cardiac Imaging and Diagnostics (27 papers), Cardiac Valve Diseases and Treatments (24 papers), Coronary Interventions and Diagnostics (24 papers) and Atrial Fibrillation Management and Outcomes (16 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (24.8k citations), Internal Medicine (2.5k citations), Surgery (11.3k citations), Radiology, Nuclear Medicine and Imaging (4.3k citations) and Immunology (3.3k citations). Marcus D Flather has collaborated with scholars based in United Kingdom, United States and Canada. Frequent co-authors include Keith A.A. Fox, Kim Allen Eagle, Salim Yusuf, Shaun G. Goodman, Philippe Gabríel Steg, Christopher Bull Granger, Álvaro Avezum, Robert Joel Goldberg, Janice M. Pogue and Frederick A. Anderson. Their work appears in journals such as European Heart Journal, Journal of the American College of Cardiology, The Lancet, Circulation and International Journal of Cardiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.